Risk of Opportunistic Infection in Adult Kidney Transplant Recipients Treated with Belatacept: A Retrospective Cohort Study

被引:0
|
作者
Lombardi, Y. [1 ]
Cassard, A. [2 ]
Chaba, A. [1 ]
Francois, H. [1 ]
机构
[1] Hop Tenon, AP HP, Soins Intensifs Nephrol & Rein Aigu, Paris, France
[2] CHU Rangueil, Nephrol, Toulouse, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
B58
引用
收藏
页码:S783 / S783
页数:1
相关论文
共 50 条
  • [11] Belatacept Conversion in Proteinuric Kidney Transplant Recipients: Data from a Retrospective Cohort and a Prospective Trial
    Efe, Orhan
    Al Jurdi, Ayman
    Wojciechowski, David
    Safa, Kassem
    Gilligan, Hannah M.
    Chandraker, Anil K.
    Azzi, Jamil R.
    Weins, Astrid
    Riella, Leonardo V.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 650 - 651
  • [12] Belatacept Conversion in Proteinuric Kidney Transplant Recipients: Effects in a Prospective Trial and a Retrospective Cohort.
    Efe, O.
    Al Jurdi, A.
    Wojciechowski, D.
    Safa, K.
    Gilligan, H.
    Chandraker, A.
    Azzi, J.
    Weins, A.
    Riella, L. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 465 - 466
  • [13] Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients
    Shen, Jinshan
    Townsend, Robert
    You, Xiaoli
    Shen, Yun
    Zhan, Ping
    Zhou, Zexun
    Geng, Dong
    Wu, Dianna
    McGirr, Nadia
    Soucek, Kathleen
    Proszynski, Elizabeth
    Pursley, Janice
    Masson, Eric
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 117 - 126
  • [14] Belatacept conversion in adolescent and young adult kidney transplant recipients
    Gupta, Charu
    Petyak, Christy
    Sgambat, Kristen
    Moudgil, Asha
    CLINICAL TRANSPLANTATION, 2023, 37 (03)
  • [15] Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients
    Jinshan Shen
    Robert Townsend
    Xiaoli You
    Yun Shen
    Ping Zhan
    Zexun Zhou
    Dong Geng
    Dianna Wu
    Nadia McGirr
    Kathleen Soucek
    Elizabeth Proszynski
    Janice Pursley
    Eric Masson
    Clinical Drug Investigation, 2014, 34 : 117 - 126
  • [16] Belatacept Conversion in Adult Kidney Transplant Recipients for Cause: A Single Center Observational Cohort.
    Savic, M.
    Cruz, M.
    Rossi, A.
    Vella, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 745 - 746
  • [17] Risk of Opportunistic Infection in Kidney Transplant Recipients with Cytomegalovirus Infection and Associated Outcomes.
    Jorgenson, M.
    Descourouez, J.
    Cardinale, B.
    Lyu, B.
    Astor, B.
    Garg, N.
    Saddler, C.
    Smith, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 834 - 834
  • [18] Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2): a retrospective cohort study
    Bertrand, Dominique
    Matignon, Marie
    Morel, Antoine
    Ludivine, Lebourg
    Lemoine, Mathilde
    Hanoy, Melanie
    Le Roy, Frank
    Nezam, Dorian
    Hamzaoui, Mouad
    de Nattes, Tristan
    Moktefi, Anissa
    Francois, Arnaud
    Laurent, Charlotte
    Etienne, Isabelle
    Guerrot, Dominique
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (02) : 481 - 490
  • [19] Belatacept reduces skin cancer risk in kidney transplant recipients
    Wang, Mike
    Mittal, Amit
    Colegio, Oscar R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 996 - 998
  • [20] CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept
    Karadkhele, Geeta
    Hogan, Julien
    Magua, Wairimu
    Zhang, Weiwen
    Badell, Idelberto Raul
    Mehta, Aneesh
    Lyon, Marshall
    Pastan, Stephen
    Pearson, Thomas C.
    Larsen, Christian P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (01) : 208 - 221